The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 50 | — | 20.1x | Near average | |
Growth | 36 | — | 5.6% | Near average | |
Quality | 14 | -58.7% | 7.6% | Below average | |
Safety | 70 | 0.4x | 0.4x | Above average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Denali Therapeutics Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Denali Therapeutics Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Denali Therapeutics stock shows a state of complete stability in analyst estimates over the past 30 days, as the average price target settled at 30.8 dollars despite currently trading at 18.64 dollar levels. This consistency in Consensus among 7 analysts indicates a continued conviction in the stock's intrinsic value, despite the significant price gap between the current market price and the lowest observed price target (23 dollars).
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.